Other Solid Tumors With Evidence of Activating RET Alteration
1 clinical trials · Condition
◉ Watch Other Solid Tumors With Evidence of Activating RET Alteration
| Record | Firm | Date |
|---|---|---|
| Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation (NCT03906331) | Eli Lilly and Company |
Track Other Solid Tumors With Evidence of Activating RET Alteration automatically
Every clearance here is in the API, with alerts when new ones post.